Martine Zimmermann - 22 Sep 2023 Form 3 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
By: /s/ Andrew Reardon For: Martine Zimmermann
Issuer symbol
LGND
Transactions as of
22 Sep 2023
Net transactions value
$0
Form type
3
Filing time
25 Sep 2023, 18:12:31 UTC
Next filing
18 Jun 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney